nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—SLC22A5—Niacin—coronary artery disease	0.0477	0.0713	CbGbCtD
Norfloxacin—SLC22A5—Furosemide—coronary artery disease	0.0314	0.0469	CbGbCtD
Norfloxacin—CYP3A7—Eplerenone—coronary artery disease	0.0304	0.0455	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0304	0.0455	CbGbCtD
Norfloxacin—SLC22A6—Enalapril—coronary artery disease	0.0297	0.0444	CbGbCtD
Norfloxacin—CYP3A5—Clopidogrel—coronary artery disease	0.0245	0.0367	CbGbCtD
Norfloxacin—CYP3A5—Eplerenone—coronary artery disease	0.0228	0.0341	CbGbCtD
Norfloxacin—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0225	0.0337	CbGbCtD
Norfloxacin—SLC22A6—Captopril—coronary artery disease	0.0222	0.0332	CbGbCtD
Norfloxacin—CYP1A2—Gemfibrozil—coronary artery disease	0.0211	0.0315	CbGbCtD
Norfloxacin—SLC22A6—Pravastatin—coronary artery disease	0.021	0.0314	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0196	0.0293	CbGbCtD
Norfloxacin—CYP3A7—Simvastatin—coronary artery disease	0.0196	0.0293	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0192	0.0287	CbGbCtD
Norfloxacin—CYP3A7—Lovastatin—coronary artery disease	0.0192	0.0287	CbGbCtD
Norfloxacin—CYP1A2—Clopidogrel—coronary artery disease	0.0183	0.0273	CbGbCtD
Norfloxacin—SLC22A6—Furosemide—coronary artery disease	0.0179	0.0267	CbGbCtD
Norfloxacin—SLC22A6—Losartan—coronary artery disease	0.0175	0.0262	CbGbCtD
Norfloxacin—CYP3A7—Atorvastatin—coronary artery disease	0.0175	0.0261	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0175	0.0261	CbGbCtD
Norfloxacin—CYP3A5—Rosuvastatin—coronary artery disease	0.0158	0.0236	CbGbCtD
Norfloxacin—CYP3A4—Ticagrelor—coronary artery disease	0.0155	0.0232	CbGbCtD
Norfloxacin—CYP3A5—Simvastatin—coronary artery disease	0.0147	0.022	CbGbCtD
Norfloxacin—CYP3A5—Lovastatin—coronary artery disease	0.0144	0.0215	CbGbCtD
Norfloxacin—CYP3A5—Pravastatin—coronary artery disease	0.0144	0.0215	CbGbCtD
Norfloxacin—CYP3A4—Fenofibrate—coronary artery disease	0.0138	0.0206	CbGbCtD
Norfloxacin—CYP3A5—Atorvastatin—coronary artery disease	0.0131	0.0196	CbGbCtD
Norfloxacin—CYP3A5—Losartan—coronary artery disease	0.012	0.0179	CbGbCtD
Norfloxacin—CYP3A4—Gemfibrozil—coronary artery disease	0.011	0.0165	CbGbCtD
Norfloxacin—CYP3A4—Clopidogrel—coronary artery disease	0.00957	0.0143	CbGbCtD
Norfloxacin—CYP1A2—Losartan—coronary artery disease	0.00892	0.0133	CbGbCtD
Norfloxacin—CYP3A4—Eplerenone—coronary artery disease	0.00889	0.0133	CbGbCtD
Norfloxacin—CYP3A4—Enalapril—coronary artery disease	0.00793	0.0119	CbGbCtD
Norfloxacin—CYP3A4—Rosuvastatin—coronary artery disease	0.00617	0.00922	CbGbCtD
Norfloxacin—CYP3A4—Ezetimibe—coronary artery disease	0.00617	0.00922	CbGbCtD
Norfloxacin—CYP3A4—Simvastatin—coronary artery disease	0.00573	0.00857	CbGbCtD
Norfloxacin—CYP3A4—Pravastatin—coronary artery disease	0.00561	0.00839	CbGbCtD
Norfloxacin—CYP3A4—Lovastatin—coronary artery disease	0.00561	0.00839	CbGbCtD
Norfloxacin—CYP3A4—Atorvastatin—coronary artery disease	0.00511	0.00764	CbGbCtD
Norfloxacin—CYP3A4—Losartan—coronary artery disease	0.00467	0.00699	CbGbCtD
Norfloxacin—TOP2A—Fluvastatin—Pitavastatin—coronary artery disease	0.000657	0.193	CbGdCrCtD
Norfloxacin—TOP2A—Fluvastatin—Rosuvastatin—coronary artery disease	0.000586	0.172	CbGdCrCtD
Norfloxacin—TOP2A—Simvastatin—Lovastatin—coronary artery disease	0.00056	0.164	CbGdCrCtD
Norfloxacin—TOP2A—Simvastatin—Pravastatin—coronary artery disease	0.00056	0.164	CbGdCrCtD
Norfloxacin—TOP2A—Fluvastatin—Atorvastatin—coronary artery disease	0.000498	0.146	CbGdCrCtD
Norfloxacin—TOP2A—Alprenolol—Penbutolol—coronary artery disease	0.000321	0.0942	CbGdCrCtD
Norfloxacin—TOP2A—Methyltestosterone—Eplerenone—coronary artery disease	0.000223	0.0655	CbGdCrCtD
Norfloxacin—Headache—Clopidogrel—coronary artery disease	7.6e-05	0.000304	CcSEcCtD
Norfloxacin—Rash—Lovastatin—coronary artery disease	7.6e-05	0.000304	CcSEcCtD
Norfloxacin—Dermatitis—Lovastatin—coronary artery disease	7.59e-05	0.000304	CcSEcCtD
Norfloxacin—Dyspepsia—Losartan—coronary artery disease	7.58e-05	0.000303	CcSEcCtD
Norfloxacin—Feeling abnormal—Perindopril—coronary artery disease	7.56e-05	0.000303	CcSEcCtD
Norfloxacin—Headache—Lovastatin—coronary artery disease	7.55e-05	0.000302	CcSEcCtD
Norfloxacin—Pruritus—Valsartan—coronary artery disease	7.53e-05	0.000302	CcSEcCtD
Norfloxacin—Dry mouth—Ramipril—coronary artery disease	7.53e-05	0.000302	CcSEcCtD
Norfloxacin—Myalgia—Timolol—coronary artery disease	7.52e-05	0.000301	CcSEcCtD
Norfloxacin—Arthralgia—Timolol—coronary artery disease	7.52e-05	0.000301	CcSEcCtD
Norfloxacin—Chest pain—Timolol—coronary artery disease	7.52e-05	0.000301	CcSEcCtD
Norfloxacin—Vomiting—Ezetimibe—coronary artery disease	7.51e-05	0.000301	CcSEcCtD
Norfloxacin—Hypersensitivity—Pravastatin—coronary artery disease	7.5e-05	0.000301	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Perindopril—coronary artery disease	7.5e-05	0.000301	CcSEcCtD
Norfloxacin—Anxiety—Timolol—coronary artery disease	7.5e-05	0.0003	CcSEcCtD
Norfloxacin—Angioedema—Lisinopril—coronary artery disease	7.49e-05	0.0003	CcSEcCtD
Norfloxacin—Pruritus—Olmesartan—coronary artery disease	7.49e-05	0.0003	CcSEcCtD
Norfloxacin—Decreased appetite—Losartan—coronary artery disease	7.48e-05	0.0003	CcSEcCtD
Norfloxacin—Abdominal pain—Captopril—coronary artery disease	7.47e-05	0.000299	CcSEcCtD
Norfloxacin—Body temperature increased—Captopril—coronary artery disease	7.47e-05	0.000299	CcSEcCtD
Norfloxacin—Dizziness—Simvastatin—coronary artery disease	7.45e-05	0.000298	CcSEcCtD
Norfloxacin—Rash—Ezetimibe—coronary artery disease	7.45e-05	0.000298	CcSEcCtD
Norfloxacin—Dermatitis—Ezetimibe—coronary artery disease	7.44e-05	0.000298	CcSEcCtD
Norfloxacin—Confusional state—Ramipril—coronary artery disease	7.44e-05	0.000298	CcSEcCtD
Norfloxacin—Asthenia—Niacin—coronary artery disease	7.42e-05	0.000297	CcSEcCtD
Norfloxacin—Fatigue—Losartan—coronary artery disease	7.42e-05	0.000297	CcSEcCtD
Norfloxacin—Headache—Ezetimibe—coronary artery disease	7.4e-05	0.000297	CcSEcCtD
Norfloxacin—Anaphylactic shock—Ramipril—coronary artery disease	7.38e-05	0.000296	CcSEcCtD
Norfloxacin—Oedema—Ramipril—coronary artery disease	7.38e-05	0.000296	CcSEcCtD
Norfloxacin—Vertigo—Lisinopril—coronary artery disease	7.37e-05	0.000295	CcSEcCtD
Norfloxacin—Dry mouth—Timolol—coronary artery disease	7.36e-05	0.000295	CcSEcCtD
Norfloxacin—Constipation—Losartan—coronary artery disease	7.36e-05	0.000295	CcSEcCtD
Norfloxacin—Vomiting—Eplerenone—coronary artery disease	7.35e-05	0.000295	CcSEcCtD
Norfloxacin—Feeling abnormal—Furosemide—coronary artery disease	7.35e-05	0.000294	CcSEcCtD
Norfloxacin—Leukopenia—Lisinopril—coronary artery disease	7.34e-05	0.000294	CcSEcCtD
Norfloxacin—Nausea—Fenofibrate—coronary artery disease	7.33e-05	0.000294	CcSEcCtD
Norfloxacin—Pruritus—Niacin—coronary artery disease	7.32e-05	0.000293	CcSEcCtD
Norfloxacin—Asthenia—Pravastatin—coronary artery disease	7.31e-05	0.000293	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Furosemide—coronary artery disease	7.29e-05	0.000292	CcSEcCtD
Norfloxacin—Rash—Eplerenone—coronary artery disease	7.29e-05	0.000292	CcSEcCtD
Norfloxacin—Urticaria—Perindopril—coronary artery disease	7.29e-05	0.000292	CcSEcCtD
Norfloxacin—Hypersensitivity—Trandolapril—coronary artery disease	7.29e-05	0.000292	CcSEcCtD
Norfloxacin—Dermatitis—Eplerenone—coronary artery disease	7.28e-05	0.000292	CcSEcCtD
Norfloxacin—Diarrhoea—Valsartan—coronary artery disease	7.28e-05	0.000292	CcSEcCtD
Norfloxacin—Confusional state—Timolol—coronary artery disease	7.27e-05	0.000291	CcSEcCtD
Norfloxacin—Hypersensitivity—Enalapril—coronary artery disease	7.26e-05	0.000291	CcSEcCtD
Norfloxacin—Body temperature increased—Perindopril—coronary artery disease	7.25e-05	0.000291	CcSEcCtD
Norfloxacin—Abdominal pain—Perindopril—coronary artery disease	7.25e-05	0.000291	CcSEcCtD
Norfloxacin—Palpitations—Lisinopril—coronary artery disease	7.25e-05	0.00029	CcSEcCtD
Norfloxacin—Diarrhoea—Olmesartan—coronary artery disease	7.25e-05	0.00029	CcSEcCtD
Norfloxacin—Headache—Eplerenone—coronary artery disease	7.24e-05	0.00029	CcSEcCtD
Norfloxacin—Thrombocytopenia—Ramipril—coronary artery disease	7.22e-05	0.000289	CcSEcCtD
Norfloxacin—Oedema—Timolol—coronary artery disease	7.21e-05	0.000289	CcSEcCtD
Norfloxacin—Anaphylactic shock—Timolol—coronary artery disease	7.21e-05	0.000289	CcSEcCtD
Norfloxacin—Pruritus—Pravastatin—coronary artery disease	7.21e-05	0.000289	CcSEcCtD
Norfloxacin—Nausea—Clopidogrel—coronary artery disease	7.2e-05	0.000289	CcSEcCtD
Norfloxacin—Vomiting—Simvastatin—coronary artery disease	7.16e-05	0.000287	CcSEcCtD
Norfloxacin—Hypersensitivity—Telmisartan—coronary artery disease	7.16e-05	0.000287	CcSEcCtD
Norfloxacin—Nausea—Lovastatin—coronary artery disease	7.16e-05	0.000287	CcSEcCtD
Norfloxacin—Hyperhidrosis—Ramipril—coronary artery disease	7.13e-05	0.000286	CcSEcCtD
Norfloxacin—Rash—Simvastatin—coronary artery disease	7.1e-05	0.000285	CcSEcCtD
Norfloxacin—Dermatitis—Simvastatin—coronary artery disease	7.1e-05	0.000284	CcSEcCtD
Norfloxacin—Asthenia—Trandolapril—coronary artery disease	7.1e-05	0.000284	CcSEcCtD
Norfloxacin—Feeling abnormal—Losartan—coronary artery disease	7.09e-05	0.000284	CcSEcCtD
Norfloxacin—Urticaria—Furosemide—coronary artery disease	7.09e-05	0.000284	CcSEcCtD
Norfloxacin—Diarrhoea—Niacin—coronary artery disease	7.08e-05	0.000284	CcSEcCtD
Norfloxacin—Asthenia—Enalapril—coronary artery disease	7.07e-05	0.000283	CcSEcCtD
Norfloxacin—Headache—Simvastatin—coronary artery disease	7.06e-05	0.000283	CcSEcCtD
Norfloxacin—Abdominal pain—Furosemide—coronary artery disease	7.05e-05	0.000282	CcSEcCtD
Norfloxacin—Body temperature increased—Furosemide—coronary artery disease	7.05e-05	0.000282	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Losartan—coronary artery disease	7.04e-05	0.000282	CcSEcCtD
Norfloxacin—Dizziness—Valsartan—coronary artery disease	7.04e-05	0.000282	CcSEcCtD
Norfloxacin—Anorexia—Ramipril—coronary artery disease	7.03e-05	0.000282	CcSEcCtD
Norfloxacin—Nausea—Ezetimibe—coronary artery disease	7.02e-05	0.000281	CcSEcCtD
Norfloxacin—Dizziness—Olmesartan—coronary artery disease	7e-05	0.000281	CcSEcCtD
Norfloxacin—Pruritus—Trandolapril—coronary artery disease	7e-05	0.00028	CcSEcCtD
Norfloxacin—Arthralgia—Lisinopril—coronary artery disease	6.98e-05	0.00028	CcSEcCtD
Norfloxacin—Myalgia—Lisinopril—coronary artery disease	6.98e-05	0.00028	CcSEcCtD
Norfloxacin—Chest pain—Lisinopril—coronary artery disease	6.98e-05	0.00028	CcSEcCtD
Norfloxacin—Hyperhidrosis—Timolol—coronary artery disease	6.97e-05	0.000279	CcSEcCtD
Norfloxacin—Asthenia—Telmisartan—coronary artery disease	6.97e-05	0.000279	CcSEcCtD
Norfloxacin—Pruritus—Enalapril—coronary artery disease	6.97e-05	0.000279	CcSEcCtD
Norfloxacin—Diarrhoea—Pravastatin—coronary artery disease	6.97e-05	0.000279	CcSEcCtD
Norfloxacin—Anxiety—Lisinopril—coronary artery disease	6.96e-05	0.000279	CcSEcCtD
Norfloxacin—Anorexia—Timolol—coronary artery disease	6.88e-05	0.000275	CcSEcCtD
Norfloxacin—Pruritus—Telmisartan—coronary artery disease	6.88e-05	0.000275	CcSEcCtD
Norfloxacin—Nausea—Eplerenone—coronary artery disease	6.87e-05	0.000275	CcSEcCtD
Norfloxacin—Dizziness—Niacin—coronary artery disease	6.84e-05	0.000274	CcSEcCtD
Norfloxacin—Urticaria—Losartan—coronary artery disease	6.84e-05	0.000274	CcSEcCtD
Norfloxacin—Dry mouth—Lisinopril—coronary artery disease	6.83e-05	0.000274	CcSEcCtD
Norfloxacin—Abdominal pain—Losartan—coronary artery disease	6.8e-05	0.000273	CcSEcCtD
Norfloxacin—Body temperature increased—Losartan—coronary artery disease	6.8e-05	0.000273	CcSEcCtD
Norfloxacin—Asthenia—Captopril—coronary artery disease	6.78e-05	0.000272	CcSEcCtD
Norfloxacin—Diarrhoea—Trandolapril—coronary artery disease	6.77e-05	0.000271	CcSEcCtD
Norfloxacin—Vomiting—Valsartan—coronary artery disease	6.77e-05	0.000271	CcSEcCtD
Norfloxacin—Confusional state—Lisinopril—coronary artery disease	6.75e-05	0.00027	CcSEcCtD
Norfloxacin—Diarrhoea—Enalapril—coronary artery disease	6.74e-05	0.00027	CcSEcCtD
Norfloxacin—Dizziness—Pravastatin—coronary artery disease	6.74e-05	0.00027	CcSEcCtD
Norfloxacin—Vomiting—Olmesartan—coronary artery disease	6.73e-05	0.00027	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.72e-05	0.000269	CcSEcCtD
Norfloxacin—Rash—Valsartan—coronary artery disease	6.71e-05	0.000269	CcSEcCtD
Norfloxacin—Dermatitis—Valsartan—coronary artery disease	6.7e-05	0.000269	CcSEcCtD
Norfloxacin—Nausea—Simvastatin—coronary artery disease	6.69e-05	0.000268	CcSEcCtD
Norfloxacin—Anaphylactic shock—Lisinopril—coronary artery disease	6.69e-05	0.000268	CcSEcCtD
Norfloxacin—Oedema—Lisinopril—coronary artery disease	6.69e-05	0.000268	CcSEcCtD
Norfloxacin—Pruritus—Captopril—coronary artery disease	6.69e-05	0.000268	CcSEcCtD
Norfloxacin—Rash—Olmesartan—coronary artery disease	6.68e-05	0.000267	CcSEcCtD
Norfloxacin—Insomnia—Ramipril—coronary artery disease	6.67e-05	0.000267	CcSEcCtD
Norfloxacin—Dermatitis—Olmesartan—coronary artery disease	6.67e-05	0.000267	CcSEcCtD
Norfloxacin—Headache—Valsartan—coronary artery disease	6.67e-05	0.000267	CcSEcCtD
Norfloxacin—Diarrhoea—Telmisartan—coronary artery disease	6.65e-05	0.000266	CcSEcCtD
Norfloxacin—Headache—Olmesartan—coronary artery disease	6.63e-05	0.000266	CcSEcCtD
Norfloxacin—Paraesthesia—Ramipril—coronary artery disease	6.63e-05	0.000265	CcSEcCtD
Norfloxacin—Asthenia—Perindopril—coronary artery disease	6.58e-05	0.000264	CcSEcCtD
Norfloxacin—Dyspnoea—Ramipril—coronary artery disease	6.58e-05	0.000264	CcSEcCtD
Norfloxacin—Vomiting—Niacin—coronary artery disease	6.58e-05	0.000264	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Timolol—coronary artery disease	6.57e-05	0.000263	CcSEcCtD
Norfloxacin—Hypersensitivity—Furosemide—coronary artery disease	6.57e-05	0.000263	CcSEcCtD
Norfloxacin—Somnolence—Ramipril—coronary artery disease	6.56e-05	0.000263	CcSEcCtD
Norfloxacin—Thrombocytopenia—Lisinopril—coronary artery disease	6.55e-05	0.000262	CcSEcCtD
Norfloxacin—Dizziness—Trandolapril—coronary artery disease	6.54e-05	0.000262	CcSEcCtD
Norfloxacin—Insomnia—Timolol—coronary artery disease	6.52e-05	0.000261	CcSEcCtD
Norfloxacin—Rash—Niacin—coronary artery disease	6.52e-05	0.000261	CcSEcCtD
Norfloxacin—Dermatitis—Niacin—coronary artery disease	6.52e-05	0.000261	CcSEcCtD
Norfloxacin—Dizziness—Enalapril—coronary artery disease	6.52e-05	0.000261	CcSEcCtD
Norfloxacin—Dyspepsia—Ramipril—coronary artery disease	6.5e-05	0.00026	CcSEcCtD
Norfloxacin—Pruritus—Perindopril—coronary artery disease	6.49e-05	0.00026	CcSEcCtD
Norfloxacin—Headache—Niacin—coronary artery disease	6.48e-05	0.00026	CcSEcCtD
Norfloxacin—Paraesthesia—Timolol—coronary artery disease	6.48e-05	0.000259	CcSEcCtD
Norfloxacin—Vomiting—Pravastatin—coronary artery disease	6.48e-05	0.000259	CcSEcCtD
Norfloxacin—Hyperhidrosis—Lisinopril—coronary artery disease	6.47e-05	0.000259	CcSEcCtD
Norfloxacin—Diarrhoea—Captopril—coronary artery disease	6.47e-05	0.000259	CcSEcCtD
Norfloxacin—Dyspnoea—Timolol—coronary artery disease	6.43e-05	0.000258	CcSEcCtD
Norfloxacin—Dizziness—Telmisartan—coronary artery disease	6.43e-05	0.000257	CcSEcCtD
Norfloxacin—Rash—Pravastatin—coronary artery disease	6.42e-05	0.000257	CcSEcCtD
Norfloxacin—Dermatitis—Pravastatin—coronary artery disease	6.42e-05	0.000257	CcSEcCtD
Norfloxacin—Decreased appetite—Ramipril—coronary artery disease	6.41e-05	0.000257	CcSEcCtD
Norfloxacin—Somnolence—Timolol—coronary artery disease	6.41e-05	0.000257	CcSEcCtD
Norfloxacin—Asthenia—Furosemide—coronary artery disease	6.4e-05	0.000256	CcSEcCtD
Norfloxacin—Headache—Pravastatin—coronary artery disease	6.38e-05	0.000256	CcSEcCtD
Norfloxacin—Anorexia—Lisinopril—coronary artery disease	6.38e-05	0.000256	CcSEcCtD
Norfloxacin—Fatigue—Ramipril—coronary artery disease	6.36e-05	0.000255	CcSEcCtD
Norfloxacin—Dyspepsia—Timolol—coronary artery disease	6.35e-05	0.000254	CcSEcCtD
Norfloxacin—Hypersensitivity—Losartan—coronary artery disease	6.34e-05	0.000254	CcSEcCtD
Norfloxacin—Nausea—Valsartan—coronary artery disease	6.32e-05	0.000253	CcSEcCtD
Norfloxacin—Pruritus—Furosemide—coronary artery disease	6.31e-05	0.000253	CcSEcCtD
Norfloxacin—Constipation—Ramipril—coronary artery disease	6.31e-05	0.000253	CcSEcCtD
Norfloxacin—Nausea—Olmesartan—coronary artery disease	6.29e-05	0.000252	CcSEcCtD
Norfloxacin—Vomiting—Trandolapril—coronary artery disease	6.29e-05	0.000252	CcSEcCtD
Norfloxacin—Diarrhoea—Perindopril—coronary artery disease	6.28e-05	0.000251	CcSEcCtD
Norfloxacin—Decreased appetite—Timolol—coronary artery disease	6.27e-05	0.000251	CcSEcCtD
Norfloxacin—Vomiting—Enalapril—coronary artery disease	6.26e-05	0.000251	CcSEcCtD
Norfloxacin—Dizziness—Captopril—coronary artery disease	6.25e-05	0.00025	CcSEcCtD
Norfloxacin—Rash—Trandolapril—coronary artery disease	6.24e-05	0.00025	CcSEcCtD
Norfloxacin—Dermatitis—Trandolapril—coronary artery disease	6.23e-05	0.00025	CcSEcCtD
Norfloxacin—Fatigue—Timolol—coronary artery disease	6.22e-05	0.000249	CcSEcCtD
Norfloxacin—Rash—Enalapril—coronary artery disease	6.21e-05	0.000249	CcSEcCtD
Norfloxacin—Dermatitis—Enalapril—coronary artery disease	6.21e-05	0.000249	CcSEcCtD
Norfloxacin—Headache—Trandolapril—coronary artery disease	6.2e-05	0.000248	CcSEcCtD
Norfloxacin—Vomiting—Telmisartan—coronary artery disease	6.18e-05	0.000248	CcSEcCtD
Norfloxacin—Asthenia—Losartan—coronary artery disease	6.17e-05	0.000247	CcSEcCtD
Norfloxacin—Headache—Enalapril—coronary artery disease	6.17e-05	0.000247	CcSEcCtD
Norfloxacin—Nausea—Niacin—coronary artery disease	6.15e-05	0.000246	CcSEcCtD
Norfloxacin—Rash—Telmisartan—coronary artery disease	6.13e-05	0.000245	CcSEcCtD
Norfloxacin—Dermatitis—Telmisartan—coronary artery disease	6.12e-05	0.000245	CcSEcCtD
Norfloxacin—Diarrhoea—Furosemide—coronary artery disease	6.1e-05	0.000244	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.1e-05	0.000244	CcSEcCtD
Norfloxacin—Pruritus—Losartan—coronary artery disease	6.09e-05	0.000244	CcSEcCtD
Norfloxacin—Headache—Telmisartan—coronary artery disease	6.09e-05	0.000244	CcSEcCtD
Norfloxacin—Feeling abnormal—Ramipril—coronary artery disease	6.08e-05	0.000244	CcSEcCtD
Norfloxacin—Dizziness—Perindopril—coronary artery disease	6.07e-05	0.000243	CcSEcCtD
Norfloxacin—Insomnia—Lisinopril—coronary artery disease	6.05e-05	0.000242	CcSEcCtD
Norfloxacin—Nausea—Pravastatin—coronary artery disease	6.05e-05	0.000242	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Ramipril—coronary artery disease	6.03e-05	0.000242	CcSEcCtD
Norfloxacin—Paraesthesia—Lisinopril—coronary artery disease	6.01e-05	0.000241	CcSEcCtD
Norfloxacin—Vomiting—Captopril—coronary artery disease	6.01e-05	0.000241	CcSEcCtD
Norfloxacin—Dyspnoea—Lisinopril—coronary artery disease	5.97e-05	0.000239	CcSEcCtD
Norfloxacin—Rash—Captopril—coronary artery disease	5.96e-05	0.000239	CcSEcCtD
Norfloxacin—Dermatitis—Captopril—coronary artery disease	5.95e-05	0.000238	CcSEcCtD
Norfloxacin—Somnolence—Lisinopril—coronary artery disease	5.95e-05	0.000238	CcSEcCtD
Norfloxacin—Feeling abnormal—Timolol—coronary artery disease	5.94e-05	0.000238	CcSEcCtD
Norfloxacin—Headache—Captopril—coronary artery disease	5.92e-05	0.000237	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Timolol—coronary artery disease	5.9e-05	0.000236	CcSEcCtD
Norfloxacin—Dizziness—Furosemide—coronary artery disease	5.9e-05	0.000236	CcSEcCtD
Norfloxacin—Dyspepsia—Lisinopril—coronary artery disease	5.89e-05	0.000236	CcSEcCtD
Norfloxacin—Diarrhoea—Losartan—coronary artery disease	5.89e-05	0.000236	CcSEcCtD
Norfloxacin—Nausea—Trandolapril—coronary artery disease	5.88e-05	0.000235	CcSEcCtD
Norfloxacin—Urticaria—Ramipril—coronary artery disease	5.86e-05	0.000235	CcSEcCtD
Norfloxacin—Nausea—Enalapril—coronary artery disease	5.85e-05	0.000234	CcSEcCtD
Norfloxacin—Vomiting—Perindopril—coronary artery disease	5.83e-05	0.000234	CcSEcCtD
Norfloxacin—Body temperature increased—Ramipril—coronary artery disease	5.83e-05	0.000234	CcSEcCtD
Norfloxacin—Abdominal pain—Ramipril—coronary artery disease	5.83e-05	0.000234	CcSEcCtD
Norfloxacin—Decreased appetite—Lisinopril—coronary artery disease	5.82e-05	0.000233	CcSEcCtD
Norfloxacin—Rash—Perindopril—coronary artery disease	5.78e-05	0.000232	CcSEcCtD
Norfloxacin—Dermatitis—Perindopril—coronary artery disease	5.78e-05	0.000232	CcSEcCtD
Norfloxacin—Nausea—Telmisartan—coronary artery disease	5.77e-05	0.000231	CcSEcCtD
Norfloxacin—Fatigue—Lisinopril—coronary artery disease	5.77e-05	0.000231	CcSEcCtD
Norfloxacin—Headache—Perindopril—coronary artery disease	5.75e-05	0.00023	CcSEcCtD
Norfloxacin—Urticaria—Timolol—coronary artery disease	5.73e-05	0.00023	CcSEcCtD
Norfloxacin—Constipation—Lisinopril—coronary artery disease	5.72e-05	0.000229	CcSEcCtD
Norfloxacin—Body temperature increased—Timolol—coronary artery disease	5.7e-05	0.000228	CcSEcCtD
Norfloxacin—Abdominal pain—Timolol—coronary artery disease	5.7e-05	0.000228	CcSEcCtD
Norfloxacin—Dizziness—Losartan—coronary artery disease	5.69e-05	0.000228	CcSEcCtD
Norfloxacin—Vomiting—Furosemide—coronary artery disease	5.67e-05	0.000227	CcSEcCtD
Norfloxacin—Rash—Furosemide—coronary artery disease	5.62e-05	0.000225	CcSEcCtD
Norfloxacin—Dermatitis—Furosemide—coronary artery disease	5.62e-05	0.000225	CcSEcCtD
Norfloxacin—Nausea—Captopril—coronary artery disease	5.61e-05	0.000225	CcSEcCtD
Norfloxacin—Headache—Furosemide—coronary artery disease	5.59e-05	0.000224	CcSEcCtD
Norfloxacin—Feeling abnormal—Lisinopril—coronary artery disease	5.51e-05	0.000221	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Lisinopril—coronary artery disease	5.47e-05	0.000219	CcSEcCtD
Norfloxacin—Vomiting—Losartan—coronary artery disease	5.47e-05	0.000219	CcSEcCtD
Norfloxacin—Nausea—Perindopril—coronary artery disease	5.45e-05	0.000218	CcSEcCtD
Norfloxacin—Hypersensitivity—Ramipril—coronary artery disease	5.44e-05	0.000218	CcSEcCtD
Norfloxacin—Rash—Losartan—coronary artery disease	5.43e-05	0.000217	CcSEcCtD
Norfloxacin—Dermatitis—Losartan—coronary artery disease	5.42e-05	0.000217	CcSEcCtD
Norfloxacin—Headache—Losartan—coronary artery disease	5.39e-05	0.000216	CcSEcCtD
Norfloxacin—Urticaria—Lisinopril—coronary artery disease	5.32e-05	0.000213	CcSEcCtD
Norfloxacin—Hypersensitivity—Timolol—coronary artery disease	5.31e-05	0.000213	CcSEcCtD
Norfloxacin—Nausea—Furosemide—coronary artery disease	5.3e-05	0.000212	CcSEcCtD
Norfloxacin—Asthenia—Ramipril—coronary artery disease	5.29e-05	0.000212	CcSEcCtD
Norfloxacin—Abdominal pain—Lisinopril—coronary artery disease	5.29e-05	0.000212	CcSEcCtD
Norfloxacin—Body temperature increased—Lisinopril—coronary artery disease	5.29e-05	0.000212	CcSEcCtD
Norfloxacin—Pruritus—Ramipril—coronary artery disease	5.22e-05	0.000209	CcSEcCtD
Norfloxacin—Asthenia—Timolol—coronary artery disease	5.18e-05	0.000207	CcSEcCtD
Norfloxacin—Nausea—Losartan—coronary artery disease	5.11e-05	0.000205	CcSEcCtD
Norfloxacin—Pruritus—Timolol—coronary artery disease	5.1e-05	0.000204	CcSEcCtD
Norfloxacin—Diarrhoea—Ramipril—coronary artery disease	5.05e-05	0.000202	CcSEcCtD
Norfloxacin—Diarrhoea—Timolol—coronary artery disease	4.94e-05	0.000198	CcSEcCtD
Norfloxacin—Hypersensitivity—Lisinopril—coronary artery disease	4.93e-05	0.000198	CcSEcCtD
Norfloxacin—Dizziness—Ramipril—coronary artery disease	4.88e-05	0.000195	CcSEcCtD
Norfloxacin—Asthenia—Lisinopril—coronary artery disease	4.8e-05	0.000192	CcSEcCtD
Norfloxacin—Dizziness—Timolol—coronary artery disease	4.77e-05	0.000191	CcSEcCtD
Norfloxacin—Pruritus—Lisinopril—coronary artery disease	4.73e-05	0.00019	CcSEcCtD
Norfloxacin—Vomiting—Ramipril—coronary artery disease	4.69e-05	0.000188	CcSEcCtD
Norfloxacin—Rash—Ramipril—coronary artery disease	4.65e-05	0.000186	CcSEcCtD
Norfloxacin—Dermatitis—Ramipril—coronary artery disease	4.65e-05	0.000186	CcSEcCtD
Norfloxacin—Headache—Ramipril—coronary artery disease	4.62e-05	0.000185	CcSEcCtD
Norfloxacin—Vomiting—Timolol—coronary artery disease	4.59e-05	0.000184	CcSEcCtD
Norfloxacin—Diarrhoea—Lisinopril—coronary artery disease	4.58e-05	0.000183	CcSEcCtD
Norfloxacin—Rash—Timolol—coronary artery disease	4.55e-05	0.000182	CcSEcCtD
Norfloxacin—Dermatitis—Timolol—coronary artery disease	4.54e-05	0.000182	CcSEcCtD
Norfloxacin—Headache—Timolol—coronary artery disease	4.52e-05	0.000181	CcSEcCtD
Norfloxacin—Dizziness—Lisinopril—coronary artery disease	4.43e-05	0.000177	CcSEcCtD
Norfloxacin—Nausea—Ramipril—coronary artery disease	4.38e-05	0.000176	CcSEcCtD
Norfloxacin—Nausea—Timolol—coronary artery disease	4.28e-05	0.000172	CcSEcCtD
Norfloxacin—Vomiting—Lisinopril—coronary artery disease	4.25e-05	0.00017	CcSEcCtD
Norfloxacin—Rash—Lisinopril—coronary artery disease	4.22e-05	0.000169	CcSEcCtD
Norfloxacin—Dermatitis—Lisinopril—coronary artery disease	4.22e-05	0.000169	CcSEcCtD
Norfloxacin—Headache—Lisinopril—coronary artery disease	4.19e-05	0.000168	CcSEcCtD
Norfloxacin—Nausea—Lisinopril—coronary artery disease	3.97e-05	0.000159	CcSEcCtD
Norfloxacin—CYP3A5—Metabolism—GOT2—coronary artery disease	7.63e-06	9.77e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	7.56e-06	9.68e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TXNRD1—coronary artery disease	7.55e-06	9.67e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP11B2—coronary artery disease	7.55e-06	9.67e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTM1—coronary artery disease	7.52e-06	9.63e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTP1—coronary artery disease	7.5e-06	9.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—DLAT—coronary artery disease	7.47e-06	9.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLIN1—coronary artery disease	7.47e-06	9.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PFKFB3—coronary artery disease	7.47e-06	9.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM2—coronary artery disease	7.47e-06	9.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—COX5B—coronary artery disease	7.47e-06	9.56e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMA6—coronary artery disease	7.44e-06	9.53e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMB5—coronary artery disease	7.44e-06	9.53e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC22A3—coronary artery disease	7.44e-06	9.53e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARGC1A—coronary artery disease	7.43e-06	9.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	7.43e-06	9.52e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HMOX1—coronary artery disease	7.4e-06	9.47e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—LPL—coronary artery disease	7.38e-06	9.45e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HADH—coronary artery disease	7.33e-06	9.39e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ARNTL—coronary artery disease	7.33e-06	9.39e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAT—coronary artery disease	7.3e-06	9.35e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CTGF—coronary artery disease	7.27e-06	9.31e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	7.22e-06	9.24e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HMGCR—coronary artery disease	7.21e-06	9.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GOT2—coronary artery disease	7.21e-06	9.23e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GPX1—coronary artery disease	7.2e-06	9.22e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOB—coronary artery disease	7.09e-06	9.07e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SULT1E1—coronary artery disease	7.08e-06	9.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	7.04e-06	9.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PLCB1—coronary artery disease	7.01e-06	8.98e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CD36—coronary artery disease	7.01e-06	8.98e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPX2—coronary artery disease	6.95e-06	8.9e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	6.95e-06	8.9e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOA2—coronary artery disease	6.95e-06	8.9e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPP2CA—coronary artery disease	6.93e-06	8.87e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—coronary artery disease	6.89e-06	8.83e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HK1—coronary artery disease	6.86e-06	8.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SULT1A1—coronary artery disease	6.86e-06	8.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPX4—coronary artery disease	6.86e-06	8.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCG5—coronary artery disease	6.86e-06	8.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	6.86e-06	8.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCA1—coronary artery disease	6.8e-06	8.71e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HADHA—coronary artery disease	6.78e-06	8.69e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—LPL—coronary artery disease	6.77e-06	8.66e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HK2—coronary artery disease	6.75e-06	8.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKR1B1—coronary artery disease	6.75e-06	8.65e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA1—coronary artery disease	6.7e-06	8.59e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—coronary artery disease	6.65e-06	8.51e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LPA—coronary artery disease	6.63e-06	8.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PLCB1—coronary artery disease	6.63e-06	8.49e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GPX1—coronary artery disease	6.6e-06	8.45e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GOT1—coronary artery disease	6.59e-06	8.43e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GGT1—coronary artery disease	6.59e-06	8.43e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	6.5e-06	8.32e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC27A1—coronary artery disease	6.47e-06	8.29e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CD36—coronary artery disease	6.43e-06	8.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCA1—coronary artery disease	6.42e-06	8.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PLCB3—coronary artery disease	6.42e-06	8.22e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOA5—coronary artery disease	6.36e-06	8.14e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LCAT—coronary artery disease	6.35e-06	8.13e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.35e-06	8.13e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPP2CA—coronary artery disease	6.35e-06	8.13e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AGT—coronary artery disease	6.31e-06	8.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—P4HB—coronary artery disease	6.23e-06	7.98e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOA4—coronary artery disease	6.23e-06	7.98e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GOT1—coronary artery disease	6.22e-06	7.97e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GGT1—coronary artery disease	6.22e-06	7.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—APOE—coronary artery disease	6.19e-06	7.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	6.17e-06	7.91e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	6.12e-06	7.84e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—APOA1—coronary artery disease	6.12e-06	7.83e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—coronary artery disease	6.09e-06	7.8e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	6.05e-06	7.75e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.02e-06	7.71e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GCLM—coronary artery disease	6.02e-06	7.71e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	5.98e-06	7.66e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTP1—coronary artery disease	5.92e-06	7.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	5.86e-06	7.5e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HMOX1—coronary artery disease	5.83e-06	7.47e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	5.83e-06	7.46e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	5.83e-06	7.46e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AGT—coronary artery disease	5.79e-06	7.41e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—VCAN—coronary artery disease	5.77e-06	7.39e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAT—coronary artery disease	5.76e-06	7.37e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.74e-06	7.35e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDOA—coronary artery disease	5.72e-06	7.33e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOE—coronary artery disease	5.67e-06	7.26e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.66e-06	7.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HADH—coronary artery disease	5.66e-06	7.25e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOA1—coronary artery disease	5.61e-06	7.18e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTP1—coronary artery disease	5.59e-06	7.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOB—coronary artery disease	5.59e-06	7.16e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—DCN—coronary artery disease	5.56e-06	7.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	5.54e-06	7.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HMOX1—coronary artery disease	5.51e-06	7.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAT—coronary artery disease	5.44e-06	6.96e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—coronary artery disease	5.44e-06	6.96e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDH2—coronary artery disease	5.4e-06	6.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARG—coronary artery disease	5.39e-06	6.9e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPX2—coronary artery disease	5.36e-06	6.87e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOA2—coronary artery disease	5.36e-06	6.87e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.36e-06	6.87e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—LPL—coronary artery disease	5.34e-06	6.83e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—POMC—coronary artery disease	5.31e-06	6.81e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.3e-06	6.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPX4—coronary artery disease	5.3e-06	6.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HK1—coronary artery disease	5.3e-06	6.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.3e-06	6.78e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOB—coronary artery disease	5.28e-06	6.76e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.27e-06	6.75e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LIPC—coronary artery disease	5.27e-06	6.74e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HBA1—coronary artery disease	5.27e-06	6.74e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	5.27e-06	6.74e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2C19—coronary artery disease	5.27e-06	6.74e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HADHA—coronary artery disease	5.23e-06	6.7e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOC3—coronary artery disease	5.23e-06	6.7e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GPX1—coronary artery disease	5.21e-06	6.67e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LDLR—coronary artery disease	5.2e-06	6.66e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.2e-06	6.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.17e-06	6.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC9A1—coronary artery disease	5.14e-06	6.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—coronary artery disease	5.14e-06	6.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—coronary artery disease	5.14e-06	6.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LPA—coronary artery disease	5.12e-06	6.55e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GCLC—coronary artery disease	5.08e-06	6.51e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CETP—coronary artery disease	5.08e-06	6.51e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CD36—coronary artery disease	5.07e-06	6.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—LPL—coronary artery disease	5.04e-06	6.46e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SDC1—coronary artery disease	5.02e-06	6.43e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPP2CA—coronary artery disease	5.01e-06	6.41e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.96e-06	6.35e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARG—coronary artery disease	4.94e-06	6.33e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GPX1—coronary artery disease	4.92e-06	6.3e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOA5—coronary artery disease	4.91e-06	6.28e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—POMC—coronary artery disease	4.87e-06	6.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALB—coronary artery disease	4.85e-06	6.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—P4HB—coronary artery disease	4.81e-06	6.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—coronary artery disease	4.8e-06	6.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CD36—coronary artery disease	4.79e-06	6.13e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMB5—coronary artery disease	4.75e-06	6.08e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMA6—coronary artery disease	4.75e-06	6.08e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.74e-06	6.07e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPP2CA—coronary artery disease	4.73e-06	6.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.72e-06	6.05e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CTGF—coronary artery disease	4.64e-06	5.94e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NOS3—coronary artery disease	4.64e-06	5.94e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GOT2—coronary artery disease	4.6e-06	5.88e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMGCR—coronary artery disease	4.6e-06	5.88e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AGT—coronary artery disease	4.56e-06	5.85e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—coronary artery disease	4.54e-06	5.81e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOE—coronary artery disease	4.47e-06	5.73e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—VCAN—coronary artery disease	4.45e-06	5.7e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALB—coronary artery disease	4.44e-06	5.69e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOA1—coronary artery disease	4.42e-06	5.66e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.42e-06	5.66e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AGT—coronary artery disease	4.31e-06	5.52e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—DCN—coronary artery disease	4.29e-06	5.49e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NOS3—coronary artery disease	4.25e-06	5.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—coronary artery disease	4.24e-06	5.43e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PLCB1—coronary artery disease	4.23e-06	5.41e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOE—coronary artery disease	4.23e-06	5.41e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOA1—coronary artery disease	4.18e-06	5.35e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.17e-06	5.34e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.15e-06	5.31e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCA1—coronary artery disease	4.1e-06	5.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HBA1—coronary artery disease	4.06e-06	5.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LIPC—coronary artery disease	4.06e-06	5.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.06e-06	5.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.06e-06	5.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOC3—coronary artery disease	4.04e-06	5.17e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LDLR—coronary artery disease	4.02e-06	5.14e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4e-06	5.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.97e-06	5.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.97e-06	5.08e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GGT1—coronary artery disease	3.97e-06	5.08e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GOT1—coronary artery disease	3.97e-06	5.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GCLC—coronary artery disease	3.92e-06	5.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CETP—coronary artery disease	3.92e-06	5.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARG—coronary artery disease	3.9e-06	4.99e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—coronary artery disease	3.89e-06	4.98e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SDC1—coronary artery disease	3.88e-06	4.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—POMC—coronary artery disease	3.84e-06	4.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARG—coronary artery disease	3.68e-06	4.71e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.66e-06	4.69e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.66e-06	4.69e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—POMC—coronary artery disease	3.63e-06	4.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CTGF—coronary artery disease	3.58e-06	4.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTP1—coronary artery disease	3.56e-06	4.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.55e-06	4.54e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GOT2—coronary artery disease	3.55e-06	4.54e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	3.53e-06	4.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMOX1—coronary artery disease	3.51e-06	4.5e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALB—coronary artery disease	3.5e-06	4.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAT—coronary artery disease	3.47e-06	4.44e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOB—coronary artery disease	3.37e-06	4.31e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NOS3—coronary artery disease	3.35e-06	4.29e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALB—coronary artery disease	3.31e-06	4.24e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—coronary artery disease	3.27e-06	4.19e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.26e-06	4.18e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LPL—coronary artery disease	3.21e-06	4.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NOS3—coronary artery disease	3.17e-06	4.05e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.16e-06	4.05e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPX1—coronary artery disease	3.14e-06	4.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—coronary artery disease	3.06e-06	3.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GOT1—coronary artery disease	3.06e-06	3.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GGT1—coronary artery disease	3.06e-06	3.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CD36—coronary artery disease	3.05e-06	3.91e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.02e-06	3.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—coronary artery disease	2.9e-06	3.71e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.89e-06	3.71e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.75e-06	3.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AGT—coronary artery disease	2.75e-06	3.52e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.72e-06	3.49e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.71e-06	3.47e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOE—coronary artery disease	2.69e-06	3.45e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAT—coronary artery disease	2.68e-06	3.43e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOA1—coronary artery disease	2.66e-06	3.41e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—coronary artery disease	2.61e-06	3.34e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOB—coronary artery disease	2.6e-06	3.33e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.55e-06	3.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.53e-06	3.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LPL—coronary artery disease	2.48e-06	3.18e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPX1—coronary artery disease	2.42e-06	3.1e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—coronary artery disease	2.39e-06	3.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CD36—coronary artery disease	2.36e-06	3.02e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARG—coronary artery disease	2.35e-06	3.01e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.33e-06	2.98e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—POMC—coronary artery disease	2.31e-06	2.96e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.23e-06	2.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—coronary artery disease	2.13e-06	2.73e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AGT—coronary artery disease	2.12e-06	2.72e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALB—coronary artery disease	2.11e-06	2.7e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOE—coronary artery disease	2.08e-06	2.66e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOA1—coronary artery disease	2.06e-06	2.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NOS3—coronary artery disease	2.02e-06	2.58e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—coronary artery disease	1.95e-06	2.5e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.89e-06	2.41e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.85e-06	2.36e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARG—coronary artery disease	1.81e-06	2.32e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—POMC—coronary artery disease	1.79e-06	2.29e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—coronary artery disease	1.78e-06	2.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALB—coronary artery disease	1.63e-06	2.09e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NOS3—coronary artery disease	1.56e-06	1.99e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—coronary artery disease	1.54e-06	1.97e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—coronary artery disease	1.46e-06	1.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.42e-06	1.82e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.14e-06	1.45e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—coronary artery disease	9.28e-07	1.19e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	8.77e-07	1.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—coronary artery disease	7.16e-07	9.17e-06	CbGpPWpGaD
